Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab.
Détails
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_90329B237134
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab.
Périodique
Clinical Rheumatology
ISSN
1434-9949[electronic]
Statut éditorial
Publié
Date de publication
2009
Volume
28
Numéro
1
Pages
93-94
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Résumé
Adalimumab is a frequently prescribed TNFalpha inhibitor for treatment of rheumatoid arthritis. We report on a patient who probably developed a Miller-Fisher syndrome after the second injection of adalimumab.
Mots-clé
Aged, Amines/therapeutic use, Antibodies, Monoclonal/adverse effects, Antirheumatic Agents/adverse effects, Arthritis, Rheumatoid/drug therapy, Azathioprine/therapeutic use, Cyclohexanecarboxylic Acids/therapeutic use, Dose-Response Relationship, Drug, Female, Glucocorticoids/therapeutic use, Humans, Miller Fisher Syndrome/etiology, Miller Fisher Syndrome/physiopathology, Treatment Outcome, Tumor Necrosis Factor-alpha/antagonists & inhibitors, gamma-Aminobutyric Acid/therapeutic use
Pubmed
Web of science
Open Access
Oui
Création de la notice
03/10/2009 12:59
Dernière modification de la notice
14/02/2022 8:56
Données d'usage
